Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celanese CorpCE · Entity 3922 | SVP, GC & Sec | February 28, 2023 | March 02, 2023 |
| Enovis CORPCFX · Entity 4797 | SVP, GC & Secretary | November 19, 2018 | November 21, 2018 |
| MARKEL GROUP INC.MKL · Entity 3229 | Director | June 15, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celanese Corp
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonqualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $116.93 · Expires 2033-02-27 | Direct | 11,551 |
Reported balance
After 2023-02-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-02-28 · Grant · Acquired 11,551 · Balance 11,551 F1: Time-based employee stock options granted under the Company's 2018 Global Incentive Plan. F2: The options vest and become exercisable, subject to continued employment, in three annual installments of 33%, 33% and 34% beginning February 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Time-based employee stock options granted under the Company's 2018 Global Incentive Plan.
F2: The options vest and become exercisable, subject to continued employment, in three annual installments of 33%, 33% and 34% beginning February 15, 2024.
Enovis CORP
Report date November 19, 2018 · Filed November 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.001SEC Table I · non-derivative | Direct | 54,818 |
Reported balance
After 2018-11-19 transaction · row 1
1 source rowRow 1 · 2018-11-19 · Sale · Disposed 2,540 · Balance 54,818 F1: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted in November 2015. |
| Common Stock, par value $.001SEC Table I · non-derivative | IndirectBy spouse | 1,111 |
Reported balance
Holding disclosure · report date 2018-11-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,111 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted in November 2015.
MARKEL GROUP INC.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 507.402 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Other · Acquired 65.9218 · Balance 507.402 F1: Shares acquired pursuant to the MKL 2020 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 1,463 |
Reported balance
Holding disclosure · report date 2026-06-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,463 F2: The reporting person and her spouse are co-trustees and beneficiaries under the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired pursuant to the MKL 2020 Employee Stock Purchase Plan.
F2: The reporting person and her spouse are co-trustees and beneficiaries under the trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2017 Filed Feb 23, 2017 21:21 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 813 | $39.74 | $32,306.99 |
DisclosureSEC source: 0001209191-17-013769 · doc4.xml · nonDerivative · entry 1 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,654 F1 · kind: These shares were sold to meet tax obligations relating to the delivery of performance-based restricted stock units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:22 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 33,698 | $0.00 Strike: $40.47 | $0.00 |
DisclosureSEC source: 0001209191-17-011059 · doc4.xml · derivative · entry 1 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,698 Underlying: Common Stock, par value $.001 · 33,698 shares Expires 2024-02-12 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,098 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · derivative · entry 9 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.001 · 8,098 shares Expires 2017-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on September 27, 2011. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon Stock, par value $.001 | 8,098 | $14.48 | $117,259.04 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · nonDerivative · entry 5 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F1 · price: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,036 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · derivative · entry 8 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,098 Underlying: Common Stock, par value $.001 · 21,036 shares Expires 2017-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on September 27, 2011. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 21,036 | $31.00 | $652,116.00 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · nonDerivative · entry 4 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,369 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F1 · price: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon Stock, par value $.001 | 21,036 | $14.48 | $304,601.28 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · nonDerivative · entry 3 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F1 · price: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · derivative · entry 7 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,134 Underlying: Common Stock, par value $.001 · 1 shares Expires 2017-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on September 27, 2011. Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 1 | $31.00 | $31.00 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · nonDerivative · entry 2 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,369 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F1 · price: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 20:43 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon Stock, par value $.001 | 1 | $14.48 | $14.48 |
DisclosureSEC source: 0001209191-16-143643 · doc4.xml · nonDerivative · entry 1 Puckett A. Lynne · CIK 0001502389 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. F1 · price: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "10b5-1 Plan") adopted by the reporting person on September 8, 2016. The 10b5-1 Plan provided for the exercise of this option tranche, which expires in September 2017, with corresponding sales to cover the exercise price and related taxes. The remaining underlying shares following this net exercise and tax sale continue to be held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.